UK markets close in 3 hours 27 minutes

Shanghai Henlius Biotech, Inc. (2696.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
22.600+0.100 (+0.44%)
At close: 04:08PM HKT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CNY. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
5,394,909
5,394,909
3,214,730
1,682,472
587,586
Cost of revenue
1,476,112
1,476,112
844,621
522,748
182,119
Gross profit
3,918,797
3,918,797
2,370,109
1,159,724
405,467
Operating expenses
Research development
1,118,732
1,118,732
1,394,514
1,023,930
894,144
Selling general and administrative
2,138,081
2,138,081
1,403,330
800,867
436,288
Total operating expenses
3,196,999
3,196,999
2,728,801
1,782,901
1,295,039
Operating income or loss
721,798
721,798
-358,692
-623,177
-889,572
Interest expense
110,539
110,539
105,672
84,820
43,705
Income before tax
569,578
569,578
-693,887
-956,739
-993,541
Income tax expense
23,559
23,559
1,372
27,313
0
Income from continuing operations
546,019
546,019
-695,259
-984,052
-993,541
Net income
546,019
546,019
-695,259
-984,052
-993,541
Net income available to common shareholders
546,019
546,019
-695,259
-984,052
-993,541
Basic EPS
-1.83
1.01
-1.28
-1.83
-1.88
Diluted EPS
-1.83
1.00
-1.28
-1.83
-1.88
Basic average shares
538,836
543,299
542,021
538,836
529,574
Diluted average shares
538,836
543,373
542,021
538,836
529,574